Company Profile

ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE1472.50-77.45 (-5 % )
PREV CLOSE (Rs.) 1549.95
OPEN PRICE (Rs.) 1472.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1472.50 (8948 )
VOLUME 4
TODAY'S LOW / HIGH (Rs.)1472.50 1472.50
52 WK LOW / HIGH (Rs.)18 2680
NSE1438.05 -75.65 (-5 % )
PREV CLOSE(Rs.) 1513.70
OPEN PRICE (Rs.) 1438.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1438.05 (3956 )
VOLUME 40
TODAY'S LOW / HIGH(Rs.) 1438.05 1438.05
52 WK LOW / HIGH (Rs.)17.15 2654.25

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.0589
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) -29.64
ROCE (%) -7.01
Incorporation Year : 1992

Management Info :

Ram Gopal Agarwal - Chairman Manish Dhanuka - Managing Director

Registered Office :

Address : Orchid Towers,313 , Valluvar Kottam High Road,Nungambakkam,
Chennai,
Tamil Nadu-600034

Phone : 044-28211000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS More
02Feb02-02-2021$ Board Meeting Intimation for Notification As Per Listing Regulations- Notice Of Meeting Of The Board Of Directors- February 09, 2021 Board Meeting Intimation fo
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve Notification as per Listing Regulations- Notice of meeting of the Board of Directors- February 09, 2021
Orchid Pharma Ltdhas informed BSE that the meeting of the Board..
15Jan01-15-2021$Orchid Pharma informs about disclosure Orchid Pharma informs about

In accordance with Regulation 31A(8)(c) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed the Company has submitted the application for reclassification of Promoters with BSE and National Stock Exchange of India today, January 15, 2021.

The above information is a part of company’s filings submitted to BSE.

In accordance with Regulation 31A(8)(c) of Securities and Excha..
01Jan01-01-2021$Orchid Pharma informs about outcome of 27th AGM Orchid Pharma informs about

Orchid Pharma has informed that the 27th Annual General Meeting (AGM) of the Company was held on December 30, 2020 at 12:00 Noon through Video conference (VC)/ Other Audio Visual Means (OAVM). In this regard, the Company enclosed the voting results along with the consolidated report of the Scrutinizer for both remote E-Voting and E-Voting as required under Regulation 44 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma has informed that the 27th Annual General Meeting..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit-453.31-1498.36
Gross Profit -453.31 -1498.36
Operating Profit -38.05-197.76
Net Sales 1026.35054.48
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Astrazeneca Pharma I (BSE)
 3802.50 (5.90%)
M.Cap ( in Cr)
8976.88
Abbott India (BSE)
 14893.15 (1.30%)
M.Cap ( in Cr)
31241.68
Dr. Reddys Lab (BSE)
 5133.00 (3.27%)
M.Cap ( in Cr)
82660.86
Pfizer (BSE)
 5413.10 (1.59%)
M.Cap ( in Cr)
24375.76
Gland Pharma (BSE)
 2830.00 (2.38%)
M.Cap ( in Cr)
45221.17
Shareholding Pattern More
PROMOTERS 98.07 %
FI/BANKS/INSURANCE 1.23 %
NON-INSTITUTION 0.66 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
GS CNX 500(G)0.01
F & O Quotes